MedPath

Evaluating the effects of rosemary capsule as adjunctive treatment in major depressive disorder

Phase 2
Recruiting
Conditions
major depressive disorder.
Mood disorder due to known physiological condition with major depressive-like episode
F06.32
Registration Number
IRCT20110310006026N11
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
44
Inclusion Criteria

Outpatient with Major Depression Based on DSM-5 Criterion, 18-55 years old, depressed patient who has never been on medication and is a candidate for SSRI treatment.

Exclusion Criteria

Pregnancy, lactation, having underlying medical or psychiatric illnesses, hypersensitivity reactions to rosemary, people at high risk of suicide, mental retardation - dependence on a variety of substances

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: At the beginning of the study and ,the fourth and eight weeks after the beginning of the study. Method of measurement: Hospital Anxiety Depression Scale (anxiety sub-scale).;Depression. Timepoint: At the beginning of the study and ,the fourth and eight weeks after the beginning of the study. Method of measurement: Beck Depression Inventory second edition.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath